19184-67-9

Basic information

• Product Name: NISTC19184679
• Synonyms: NISTC19184679;3,3-Dimethylglutaric acid dimethyl;3,3-Dimethylglutaric acid dimethyl ester;3,3-Dimethylpentanedioic acid dimethyl;3,3-Dimethylpentanedioic acid dimethyl ester;dimethyl 3,3-dimethylpentanedioate;Dimethyl 3,3-dimethylglutarate;3,3-Dimethyl-Pentanedioic Acid Dimethyl Ester(WX618056)
• CAS NO: 19184-67-9
• Molecular Formula: C₉H₁₆O₄
• Molecular Weight: 188.22094
• Mol File: 19184-67-9.mol
• Article Data: 8

Chemical Properties

• Boiling Point: 243.23°C (rough estimate)
• Flash Point: 86.2°C
• Appearance: /
• Density: 1.0360
• Vapor Pressure: 0.301mmHg at 25°C
• Refractive Index: 1.4199 (estimate)
• CAS DataBase Reference: NISTC19184679(CAS DataBase Reference)
• NIST Chemistry Reference: NISTC19184679(19184-67-9)
• EPA Substance Registry System: NISTC19184679(19184-67-9)

Safety Data

• Hazardous Substances Data: 19184-67-9(Hazardous Substances Data)

Usage

General Description

NISTC19184679 is the chemical identifier for bis(2-ethylhexyl) phthalate, also known as diethylhexyl phthalate (DEHP). DEHP is a colorless liquid with a mild, pleasant odor and is commonly used as a plasticizer in the production of various consumer products, including food packaging, toys, medical devices, and vinyl flooring. It is known to have endocrine-disrupting properties and has been linked to adverse health effects, including reproductive and developmental issues, as well as being a potential carcinogen. DEHP has been regulated and restricted in many countries due to its potential health risks, with efforts to find safer alternatives for its various applications.

InChI:InChI=1/C9H16O4/c1-9(2,5-7(10)12-3)6-8(11)13-4/h5-6H2,1-4H3

Upstream product

• 1125-11-7 methyldimedone 
• 126-81-8 dimedone 
• 1195-91-1 2-bromodimedone 
• 41893-60-1 N-(1-Methoxy-3-oxo-1-cyclopenten-2-yl)benzamid 
• 186581-53-3 diazomethane 
• 4839-46-7 3,3-Dimethylglutaric acid 
• 67-56-1 methanol 

Downstream Products

• 42052-41-5 (3,3-dimethyl-5-phenylcyclopenta-1,4-dien-1-yl)benzene 
• 99342-81-1 5,5-dimesityl-3,3-dimethyl-5-hydroxypentanoic acid lactone 
• 19916-44-0 5,5-Dimethyl-2-methylsulfinyl-3-methylsulfinylmethyl-Δ²-cyclohexenon-(1) 
• 19916-46-2 5,5-Dimethyl-2-phenylsulfonyl-3-phenylsulfonylmethyl-Δ²-cyclohexenon-(1) 
• 19916-45-1 5,5-Dimethyl-2-methylsulfonyl-3-methylsulfonylmethyl-Δ²-cyclohexenon-(1) 
• 858859-11-7 3,3-Dimethyl-1,1,5,5-tetraphenyl-1,5-pentanediol 
• 1470169-11-9 C₃₁H₃₃N₃O₆ 
• 1470169-09-5 C₃₁H₃₂N₂O₇ 
• 19916-55-3 2-Methylsulfinyl-3,5,5-trimethyl-Δ²-cyclohexenon-(1) 
• 19916-56-4 2-Methylmercapto-3,5,5-trimethyl-Δ²-cyclohexenon 
• 22748-16-9 4,4-dimethylcyclopent-2-ene-1-one 
• 1638-26-2 1,1-Dimethylcyclopentane 
• 66606-40-4 4,4-dimethyl-trans-1,2-cyclopentanediol 
• 123003-38-3 4,4-Dimethyl-2,2,6,6-tetraphenyl-tetrahydro-pyran 

Relevant articles and documents

Me2AlSEt-promoted domino dieckmann cyclization enables the total synthesis of polycyclic polyprenylated acylphloroglucinols

A bioinspired, Me2AlSEt-promoted domino Dieckmann cyclization via an 8-membered ring intermediate to construct bicyclo[3.3.1]nonanes was developed, and the divergent syntheses of nine complex polycyclic polyprenylated acylphloroglucinols were a

ANTIVIRAL COMPOUNDS

The present invention relates to novel compounds of general formula (I) wherein the groups X, and R1 to R4 have the meanings given in the description and claims, process for preparing these compounds and their use as for treating, preventing or ameliorating viral infections and their use for treating, preventing or ameliorating diseases which are associated with PLA2G16.

184. Stereoselective Hydrolysis of Substituted Cyclopropanedicarboxylates with Pig Liver Esterase

The hydrolysis of the meso-cyclopropane-1,2-dicarboxylates 1a-3a, 4, 5a, 6a, and 9, containing various substituents at C(3), and of the rac-3-phenylcyclopropane-1,2-dicarboxylates 7a, 8a, and 10 with pig liver esterase (PLE) is described.The stereoselectivity and absolute configurations of the products were determined.An interpretation of results was attempted on the basis of a recent active-site model for PLE.